2705, boulevard Laurier
R-1742
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
Information non disponible
- Leblanc, MylèneEmployéCHUL+1 418-525-4444, poste 42296 / 72186Mylene.Leblanc@crchudequebec.ulaval.ca
2705, boulevard Laurier
T0-27
Québec, Québec
Canada G1V 4G2
Does Growth Velocity Affect Associations between Birth Weight and Neurodevelopment for Infants Born Very Preterm
Article de revueJ Pediatr, 260 , 2023.
Maternal High-Dose DHA Supplementation and Neurodevelopment at 18-22 Months of Preterm Children
Article de revuePediatrics, 150 (1), 2022.
Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool age of a randomised clinical trial (MOBYDIckPS)
Article de revueBMJ Open, 12 (5), 2022.
Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study
Article de revueJ Pediatric Infect Dis Soc, 10 (3), 2021.
Cost-analysis of Withdrawing Immunoprophylaxis for Respiratory Syncytial Virus in Infants Born at 33-35 Weeks Gestational Age in Quebec: A Multicenter Retrospective Study
Article de revuePediatr Infect Dis J, 39 (8), 2020.
Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial
Article de revueJAMA, 324 (2), 2020.
Efficacy of minimally invasive surfactant therapy in moderate and late preterm infants: A multicentre randomized control trial
Article de revuePaediatr Child Health, 22 (3), 2017.
Association between Apnea of Prematurity and Respiratory Distress Syndrome in Late Preterm Infants: An Observational Study
Article de revueFront Pediatr, 4 , 2016.
Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children
Article de revueJ Infect Dis, 206 (2), 2012.
A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
Article de revueEur J Clin Microbiol Infect Dis, 31 (10), 2012.
Projets actifs
- Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized controlled trial (MOBYDIck trial), du 2014-07-01 au 2025-12-25
Projets terminés récemment
- Vaccine coverage in preterm population, du 2022-03-14 au 2022-05-01